Suppr超能文献

含有抗菌喹诺酮配体的 VO 复合物及其与血清蛋白的相互作用。

VO complexes with antibacterial quinolone ligands and their interaction with serum proteins.

机构信息

Istituto CNR di Chimica Biomolecolare, Trav. La Crucca 3, I-07040 Sassari, Italy.

出版信息

Dalton Trans. 2018 Feb 13;47(7):2164-2182. doi: 10.1039/c7dt04216g.

Abstract

Quinolone derivatives are among the most commonly prescribed antibacterials in the world and could also attract interest as organic ligands in the design of metal complexes with potential pharmacological activity. In this study, five compounds, belonging to the first (nalidixic acid or Hnal), second (ciprofloxacin or Hcip, and norfloxacin or Hnor) and third generation (levofloxacin or Hlev, and sparfloxacin or Hspar) of quinolones, were used as ligands to bind the VO ion. In aqueous solution, mono- and bis-chelated species were formed as a function of pH, with cis-[VOHL(HO)] and [VOHL], x = 0-2, being the major complexes at pH 7.4. DFT calculations indicate that the most stable isomers are the octahedral OC-6-32 and the square pyramidal SPY-5-12, in equilibrium with each other. To the best of our knowledge, this is the first case that an equilibrium between a penta-coordinated square pyramidal complex and a hexa-coordinated octahedral complex is observed in solution for ligands forming six-membered chelated rings. Nalidixic acid forms the solid compound [VO(nal)(HO)], to which a cis-octahedral geometry was assigned. The interaction with 1-methylimidazole (MeIm) causes a shift of the equilibrium SPY-5 + HO ⇄ OC-6 toward the right after the formation of cis-[VOHL(MeIm)], where MeIm replaces an equatorial water ligand. The study of the systems containing [VO(nal)(HO)] and the serum proteins - albumin (HSA), apo-transferrin (apo-hTf) and holo-transferrin (holo-hTf) - indicates that HSA and holo-hTf form the mixed species {VO(nal)}(HSA) and {VO(nal)}(holo-hTf), where y = 1-3 denotes the number of VO(nal) moieties bound to accessible histidines (His105, His367, His510 for HSA, and His25, His349, His606 for holo-hTf), whereas apo-hTf yields VO(nal)(apo-hTf) with the coordination of the His289 residue only. Docking calculations suggest that the specific conformation of apo-hTf and the steric hindrance of the cis-VO(nal) moiety interfere with its interaction with all the surface His residues and the formation of a hydrogen bond network which could stabilize the binding sites.

摘要

喹诺酮衍生物是世界上最常用的抗菌药物之一,也可能作为有机配体引起人们的兴趣,用于设计具有潜在药理活性的金属配合物。在这项研究中,五种化合物,属于第一代(萘啶酸或 Hnal)、第二代(环丙沙星或 Hcip 和诺氟沙星或 Hnor)和第三代(左氧氟沙星或 Hlev 和司帕沙星或 Hspar)喹诺酮类药物,被用作结合 VO 离子的配体。在水溶液中,形成了单核和双核配合物,这是 pH 的函数,在 pH 7.4 时,主要配合物为 cis-[VOHL(HO)]和[VOHL],x=0-2。DFT 计算表明,最稳定的异构体是八面体 OC-6-32 和四面体形 SPY-5-12,它们处于平衡状态。据我们所知,这是第一个在溶液中观察到形成六元螯合环的配体的五配位四方锥形配合物和六配位八面体配合物之间的平衡的例子。萘啶酸形成了固态化合物[VO(nal)(HO)],其被赋予了顺式八面体几何形状。与 1-甲基咪唑(MeIm)的相互作用导致在形成 cis-[VOHL(MeIm)]后,SPY-5+HO ⇄ OC-6 的平衡向右移动,其中 MeIm 取代了一个赤道水配体。对含有[VO(nal)(HO)]和血清蛋白 - 白蛋白(HSA)、脱铁转铁蛋白(apo-hTf)和全铁转铁蛋白(holo-hTf)的系统的研究表明,HSA 和 holo-hTf 形成混合物种{VO(nal)}(HSA)和{VO(nal)}(holo-hTf),其中 y=1-3 表示结合到可及组氨酸(HSA 的 His105、His367、His510 和 holo-hTf 的 His25、His349、His606)上的 VO(nal)部分的数量,而 apo-hTf 仅与 His289 残基配位生成 VO(nal)(apo-hTf)。对接计算表明,apo-hTf 的特定构象和 cis-VO(nal)部分的空间位阻干扰了其与所有表面 His 残基的相互作用以及形成稳定结合位点的氢键网络的形成。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验